World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer ; volume:07 ; number:03 ; year:2020 ; pages:073-074
Global medical genetics ; 07, Heft 03 (2020), 073-074
- Beteiligte Personen und Organisationen
-
Liu, Qian
- DOI
-
10.1055/s-0040-1721451
- URN
-
urn:nbn:de:101:1-2021022618521431994870
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Qian
Ähnliche Objekte (12)
Die klinisch-onkologische Bedeutung von Tumormarkern beim Mammakarzinom unter besonderer Berücksichtigung des mucin like carcinoma associated Antigen (MCA)
Laparoscopy-assisted Distal Gastrectomy should become a Standard Surgical Treatment Option for Stage IA/IB Gastric Cancer
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
CRISPR-Cas9 and T cells
Kinetically stabilized 1,3-diarylisobenzofurans and the possibility of preparing large, persistent isoacenofurans with unusually small HOMO–LUMO gaps
CRISPR/Cas9 genome engineering in hematopoietic cells
Direct conversion of somatic cells utilizing CRISPR/Cas9
Development of a genome-editing CRISPR/Cas9 system in thermophilic fungal Myceliophthora species and its application to hyper-cellulase production strain engineering
Fuzzy Logic-based Virtual Cell Design in Ultra-Dense Networks
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
The duration of paid parental leave and children's scholastic performance
Die klinisch-onkologische Bedeutung von Tumormarkern beim Mammakarzinom unter besonderer Berücksichtigung des mucin like carcinoma associated Antigen (MCA)
Laparoscopy-assisted Distal Gastrectomy should become a Standard Surgical Treatment Option for Stage IA/IB Gastric Cancer
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
CRISPR-Cas9 and T cells
Kinetically stabilized 1,3-diarylisobenzofurans and the possibility of preparing large, persistent isoacenofurans with unusually small HOMO–LUMO gaps
CRISPR/Cas9 genome engineering in hematopoietic cells
Direct conversion of somatic cells utilizing CRISPR/Cas9
Development of a genome-editing CRISPR/Cas9 system in thermophilic fungal Myceliophthora species and its application to hyper-cellulase production strain engineering
Fuzzy Logic-based Virtual Cell Design in Ultra-Dense Networks
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
The duration of paid parental leave and children's scholastic performance
Die klinisch-onkologische Bedeutung von Tumormarkern beim Mammakarzinom unter besonderer Berücksichtigung des mucin like carcinoma associated Antigen (MCA)
Laparoscopy-assisted Distal Gastrectomy should become a Standard Surgical Treatment Option for Stage IA/IB Gastric Cancer
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
CRISPR-Cas9 and T cells
Kinetically stabilized 1,3-diarylisobenzofurans and the possibility of preparing large, persistent isoacenofurans with unusually small HOMO–LUMO gaps
CRISPR/Cas9 genome engineering in hematopoietic cells
Direct conversion of somatic cells utilizing CRISPR/Cas9
Development of a genome-editing CRISPR/Cas9 system in thermophilic fungal Myceliophthora species and its application to hyper-cellulase production strain engineering
Fuzzy Logic-based Virtual Cell Design in Ultra-Dense Networks
CRISPR–Cas9 applications in T cells and adoptive T cell therapies
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease